Prime Medicine PRME EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Prime Medicine’s reported figures.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's EBIT?
- Prime Medicine (PRME) reported EBIT of -$50.65M in Q1 2026.
- How has Prime Medicine's EBIT changed year-over-year?
- Prime Medicine's EBIT increased by 3.3% year-over-year, from -$52.39M to -$50.65M.
- What is the long-term trend for Prime Medicine's EBIT?
- Over 3 years (2022 to 2025), Prime Medicine's EBIT has grown at a 21.4% compound annual growth rate (CAGR), from -$116.54M to -$208.35M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.